{
  "run_id": "RUN_20260204_234342_996d5a3920e1",
  "timestamp": "2026-02-05T03:51:01.429105",
  "document": "Ataxia-Telangiectasia.pdf",
  "document_path": "/Users/frederictetard/Projects/ese/gold_data/NLP4RARE/train/Ataxia-Telangiectasia.pdf",
  "pipeline_version": "0.8",
  "total_candidates": 7,
  "total_validated": 7,
  "total_rejected": 0,
  "total_ambiguous": 0,
  "diseases": [
    {
      "matched_text": "respiratory infections",
      "preferred_label": "respiratory tract infectious disorder",
      "abbreviation": null,
      "confidence": 0.85,
      "is_rare_disease": false,
      "category": "pulmonology",
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0024355",
        "orpha": null,
        "umls": null,
        "mesh": "MESH:D012141"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0024355",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:519.8",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D012141",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:275498002",
          "display": null
        }
      ],
      "context": "(ataxia), the development of reddish lesions of the skin and mucous membranes due to permanent widening of groups of blood vessels (telangiectasia), and impaired functioning of the immune system (i.e., cellular and humoral immunodeficiency), resulting in increased susceptibility to upper and lower respiratory infections (sinopulmonary infections). Individuals with AT also have an increased risk of developing certain malignancies, particularly of the lymphatic system (lymphomas), the blood-forming organs (e.g., leukemia), and the brain. Ataxia telangiectasia usually begins during infancy (between one and three year",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": null,
      "enrichment_source": null
    },
    {
      "matched_text": "Ataxia telangiectasia",
      "preferred_label": "ataxia telangiectasia",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0008840",
        "orpha": "Orphanet:100",
        "umls": "UMLS:C0004135",
        "mesh": "MESH:D001260"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0008840",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:12704",
          "display": null
        },
        {
          "system": "GARD",
          "code": "GARD:5862",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:334.8",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:439",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D001260",
          "display": null
        },
        {
          "system": "MedDRA",
          "code": "MedDRA:10003594",
          "display": null
        },
        {
          "system": "NANDO",
          "code": "NANDO:2200705",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C2887",
          "display": null
        },
        {
          "system": "NORD",
          "code": "NORD:816",
          "display": null
        },
        {
          "system": "OMIM",
          "code": "OMIM:208900",
          "display": null
        },
        {
          "system": "Orphanet",
          "code": "Orphanet:100",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:68504005",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0004135",
          "display": null
        }
      ],
      "context": "Ataxia telangiectasia (AT) is a complex genetic neurodegenerative disorder that may become apparent during infancy or early childhood. The disorder is characterized by progressively impaired coordination of voluntary movements (ataxia), the development of reddish lesions of the skin and mucous membranes due to permanent",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Nijmegen Breakage Syndrome",
        "Early-onset ataxia with oculomotor apraxia and hypoalbuminemia",
        "Ataxia Telangiectasia Like Disorder"
      ],
      "pubtator_normalized_name": "Ataxia Telangiectasia",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "immunodeficiency",
      "preferred_label": "immunodeficiency",
      "abbreviation": null,
      "confidence": 0.85,
      "is_rare_disease": false,
      "category": "immunology",
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0021094",
        "orpha": null,
        "umls": "UMLS:C0021051",
        "mesh": "D000163"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0021094",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:279.3",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:7034",
          "display": null
        },
        {
          "system": "NANDO",
          "code": "NANDO:2100204",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C3131",
          "display": null
        },
        {
          "system": "OMIMPS",
          "code": "OMIMPS:300755",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:234532001",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0021051",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D000163",
          "display": "Acquired Immunodeficiency Syndrome"
        }
      ],
      "context": "characterized by progressively impaired coordination of voluntary movements (ataxia), the development of reddish lesions of the skin and mucous membranes due to permanent widening of groups of blood vessels (telangiectasia), and impaired functioning of the immune system (i.e., cellular and humoral immunodeficiency), resulting in increased susceptibility to upper and lower respiratory infections (sinopulmonary infections). Individuals with AT also have an increased risk of developing certain malignancies, particularly of the lymphatic system (lymphomas), the blood-forming organs (e.g., leukemia), and the brai",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Immunodeficiency due to Defect in MAPBP-Interacting Protein",
        "Lymphoproliferative Disorders",
        "X-Linked Combined Immunodeficiency Diseases"
      ],
      "pubtator_normalized_name": "Acquired Immunodeficiency Syndrome",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "telangiectasia",
      "preferred_label": "telangiectasia",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0001576",
        "orpha": null,
        "umls": "UMLS:C0039446",
        "mesh": "MESH:D013684"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0001576",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:1272",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:21088",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D013684",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C28194",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:247479008",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0039446",
          "display": null
        }
      ],
      "context": "rative disorder that may become apparent during infancy or early childhood. The disorder is characterized by progressively impaired coordination of voluntary movements (ataxia), the development of reddish lesions of the skin and mucous membranes due to permanent widening of groups of blood vessels (telangiectasia), and impaired functioning of the immune system (i.e., cellular and humoral immunodeficiency), resulting in increased susceptibility to upper and lower respiratory infections (sinopulmonary infections). Individuals with AT also have an increased risk of developing certain malignancies, particularly",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Telangiectasia Hereditary Hemorrhagic",
        "Central Nervous System Vascular Malformations",
        "Telangiectasis"
      ],
      "pubtator_normalized_name": "Ataxia Telangiectasia",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "lymphomas",
      "preferred_label": "lymphoma",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": "oncology",
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0005062",
        "orpha": "Orphanet:223735",
        "umls": "UMLS:C0024299",
        "mesh": "MESH:D008223"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0005062",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:0060058",
          "display": null
        },
        {
          "system": "EFO",
          "code": "EFO:0000574",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:202.80",
          "display": null
        },
        {
          "system": "ICDO",
          "code": "ICDO:9590/3",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:44223",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D008223",
          "display": null
        },
        {
          "system": "MedDRA",
          "code": "MedDRA:10025310",
          "display": null
        },
        {
          "system": "NANDO",
          "code": "NANDO:2100004",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C3208",
          "display": null
        },
        {
          "system": "ONCOTREE",
          "code": "ONCOTREE:MLYM",
          "display": null
        },
        {
          "system": "Orphanet",
          "code": "Orphanet:223735",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:373168002",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0024299",
          "display": null
        }
      ],
      "context": "g of the immune system (i.e., cellular and humoral immunodeficiency), resulting in increased susceptibility to upper and lower respiratory infections (sinopulmonary infections). Individuals with AT also have an increased risk of developing certain malignancies, particularly of the lymphatic system (lymphomas), the blood-forming organs (e.g., leukemia), and the brain. Ataxia telangiectasia usually begins during infancy (between one and three years of age) and often affects more than one child in a family. Males and females may be affected in equal numbers. In the United States, the prevalence is approxi",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Lymphoma Non-Hodgkin",
        "Lymphoma B-Cell",
        "Lymphoma Large B-Cell Diffuse"
      ],
      "pubtator_normalized_name": "Lymphoma",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "leukemia",
      "preferred_label": "leukemia",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": "oncology",
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0005059",
        "orpha": null,
        "umls": "UMLS:C0023418",
        "mesh": "MESH:D007938"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0005059",
          "display": null
        },
        {
          "system": "DOID",
          "code": "DOID:1240",
          "display": null
        },
        {
          "system": "EFO",
          "code": "EFO:0000565",
          "display": null
        },
        {
          "system": "HP",
          "code": "HP:0001909",
          "display": null
        },
        {
          "system": "ICD9",
          "code": "ICD9:208.90",
          "display": null
        },
        {
          "system": "ICDO",
          "code": "ICDO:9800/3",
          "display": null
        },
        {
          "system": "MEDGEN",
          "code": "MEDGEN:9725",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "MESH:D007938",
          "display": null
        },
        {
          "system": "NANDO",
          "code": "NANDO:2100002",
          "display": null
        },
        {
          "system": "NCIT",
          "code": "NCIT:C3161",
          "display": null
        },
        {
          "system": "SCTID",
          "code": "SCTID:93143009",
          "display": null
        },
        {
          "system": "UMLS",
          "code": "UMLS:C0023418",
          "display": null
        }
      ],
      "context": "umoral immunodeficiency), resulting in increased susceptibility to upper and lower respiratory infections (sinopulmonary infections). Individuals with AT also have an increased risk of developing certain malignancies, particularly of the lymphatic system (lymphomas), the blood-forming organs (e.g., leukemia), and the brain. Ataxia telangiectasia usually begins during infancy (between one and three years of age) and often affects more than one child in a family. Males and females may be affected in equal numbers. In the United States, the prevalence is approximately one in 40,000-100,000 live births.",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Leukemia Myeloid Acute",
        "Leukemia Lymphocytic Chronic B-Cell",
        "Leukemia Myelogenous Chronic BCR-ABL Positive"
      ],
      "pubtator_normalized_name": "Leukemia",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "ataxia",
      "preferred_label": "ataxia",
      "abbreviation": null,
      "confidence": 0.95,
      "is_rare_disease": false,
      "category": null,
      "codes": {
        "icd10": null,
        "icd11": null,
        "snomed": null,
        "mondo": "MONDO:MONDO_0100308",
        "orpha": null,
        "umls": null,
        "mesh": "D001259"
      },
      "all_identifiers": [
        {
          "system": "MONDO",
          "code": "MONDO_0100308",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D001259",
          "display": "Ataxia"
        }
      ],
      "context": "Ataxia telangiectasia (AT) is a complex genetic neurodegenerative disorder that may become apparent during infancy or early childhood. The disorder is characterized by progressively impaired coordination of voluntary movements (ataxia), the development of reddish lesions of the skin and mucous membranes due to permanent widening of groups of blood vessels (telangiectasia), and impaired functioning of the immune system (i.e., cellular and humoral immunodeficiency), resulting in increased susceptibility to upper and lower respirat",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_mondo_diseases.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "Ataxia Telangiectasia",
        "Ataxia Neuropathy Spectrum",
        "Leukoencephalopathies"
      ],
      "pubtator_normalized_name": "Ataxia",
      "enrichment_source": "pubtator3"
    }
  ]
}